Details of the Drug

General Information of Drug (ID: DMYAXNM)

Drug Name

SRK-015

Synonyms

Apitegromab

Indication

Disease Entry	ICD 11	Status	REF
Spinal muscular atrophy	8B61	Phase 2	[1]
------------------------------------------------------------------------------------

Drug Type

Antibody

Cross-matching ID

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	ClinicalTrials.gov (NCT03921528) An Active Treatment Study of SRK-015 in Patients With Type 2 or Type 3 Spinal Muscular Atrophy (TOPAZ). U.S. National Institutes of Health.
2	Clinical pipeline report, company report or official report of Scholar Rock.